Olpasiran
amgen
[]
promising data from the novel subq sirna olpasiran in pts with atherosclerotic disease and high lp(a), learn more in this interview with dr o donoghue on results from the ocean(a)-dose trial #aha22 url here: 
Non-Profit Founder/Leader | ?? Doc | Artist | Scientist | Educator | News Anchor https://t.co/usmuA3tKft | RT ? endorse | Disclaimer: https://t.co/bwmE2O3U5W